Larry Rubinstein
Impact in
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Pulmonary and Respiratory Medicine top 0.02%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 68
- PARP inhibition in cancer therapy 19
- Colorectal Cancer Treatments and Studies 18
-
- Cancer therapeutics and mechanisms 12
- Co-authors
- Susan G. Arbuck (6 shared papers)Richard Kaplan (5 shared papers)Michaele C. Christian (8 shared papers)Daniel J. Sargent (7 shared papers)Janet Dancey (7 shared papers)Lawrence H. Schwartz (5 shared papers)Lori E. Dodd (6 shared papers)Margaret Mooney (6 shared papers)
- Journals
- Journal of Clinical Oncology (51 papers)Clinical Cancer Research (15 papers)JNCI Journal of the National Cancer Institute (10 papers)Cancer Research (9 papers)European Journal of Cancer (8 papers)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
Larry Rubinstein
192 papers receiving 48.3k citations
Larry Rubinstein's Hit Papers
Peers
Comparison fields: 5 of 193
- Oncology 13.8k
- Pulmonary and Respiratory Medicine 13.6k
- Hepatology 3.1k
- Cancer Research 4.6k
- Otorhinolaryngology 988
Countries citing papers authored by Larry Rubinstein
This map shows the geographic impact of Larry Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Rubinstein more than expected).
Fields of papers citing papers by Larry Rubinstein
This network shows the impact of papers produced by Larry Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Rubinstein. The network helps show where Larry Rubinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Hit paper breakdown → | 2008 | 21468 |
| 2 | New Guidelines to Evaluate the Response to Treatment in Solid Tumors Hit paper breakdown → | 2000 | 13832 |
| 3 | Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer Hit paper breakdown → | 1995 | 2222 |
| 4 | Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Hit paper breakdown → | 1990 | 871 |
| 5 | Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm Hit paper breakdown → | 1989 | 861 |
| 6 | Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials Hit paper breakdown → | 2001 | 687 |
| 7 | Modern thirty-day operative mortality for surgical resections in lung cancer Hit paper breakdown → | 1983 | 542 |
| 8 | 2005 | 481 | |
| 9 | 1997 | 471 | |
| 10 | 2005 | 337 | |
| 11 | 2005 | 272 | |
| 12 | 1984 | 269 | |
| 13 | 1992 | 268 | |
| 14 | 2009 | 246 | |
| 15 | 1999 | 237 | |
| 16 | 2017 | 227 | |
| 17 | 1981 | 209 | |
| 18 | 1994 | 204 | |
| 19 | 2020 | 199 | |
| 20 | 1990 | 194 |
About Larry Rubinstein
Larry Rubinstein is a scholar working on Oncology, Molecular Biology, Statistics and Probability, Pulmonary and Respiratory Medicine and Cancer Research, having authored 201 papers that have together received 49.5k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (41 papers), Cancer Genomics and Diagnostics (30 papers), Lung Cancer Treatments and Mutations (25 papers), PARP inhibition in cancer therapy (19 papers), Colorectal Cancer Treatments and Studies (18 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Cancer therapeutics and mechanisms (12 papers) and Computational Drug Discovery Methods (11 papers). The work is most often cited by research in Oncology (13.8k citations), Pulmonary and Respiratory Medicine (13.6k citations), Hepatology (3.1k citations), Cancer Research (4.6k citations) and Otorhinolaryngology (988 citations). Larry Rubinstein has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Susan G. Arbuck, Richard Kaplan, Michaele C. Christian, Daniel J. Sargent, Janet Dancey, Lawrence H. Schwartz, Lori E. Dodd, Margaret Mooney, Lalitha Shankar and Denis Lacombe. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JNCI Journal of the National Cancer Institute, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.